Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
Clinical trial NCT01060202 · COMPLETED
Trial details
- NCT number
- NCT01060202
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.